Curaleaf Holdings, Inc. CURLF
—
11.07
(0.15)
(1.34%)
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow CURLF
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.69 | 1.51 | 1.29 | 2.16 | |
P/FCF ratio |
30.02 | 26.04 | 29.97 | 38.04 | |
P/Operating CF |
44.08 | 45.37 | 79.06 | 97.20 | |
P/B ratio |
2.41 | 2.54 | 2.02 | 3.28 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.29 | 2.12 | 1.89 | 2.79 | |
EV/EBITDA |
11.31 | 11.12 | 10.43 | 15.96 | |
EV/Operating CF |
19.81 | 19.51 | 20.16 | 26.00 | |
EV/FCF |
40.59 | 36.43 | 43.79 | 49.04 | |
Quick Ratio |
0.59 | 0.60 | 0.60 | 0.59 | |
Current Ratio |
1.47 | 1.52 | 1.56 | 1.52 | |
Net Debt/EBITDA |
12.56 | 13.10 | 14.31 | 14.20 | |
Debt/Assets |
29.77% | 30.49% | 30.98% | 32.99% | |
Debt/Equity |
0.97 | 1.15 | 1.06 | 1.07 | |
Asset Turnover |
0.42 | 0.44 | 0.45 | 0.46 | |
Operating CF/Net income |
(0.85) | (0.71) | 0.30 | 2.34 | |
Capex/Depreciation |
(0.30) | (0.31) | (0.32) | (0.30) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
37.62% | 36.75% | 37.90% | 38.72% | |
Intangible Assets out of Total Assets |
0.58 | 0.58 | 0.57 | 0.56 | |
Share Based Compensation of Revenue |
3.21% | 3.73% | 2.98% | 3.08% | |
Graham Net Nets |
(0.73) | (0.85) | (0.92) | (0.52) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(11.47%) | (11.90%) | (6.07%) | (1.20%) | |
Free Cash Flow Yield |
3.33% | 3.84% | 3.34% | 2.63% | |
Revenue per Share |
1.26 | 1.30 | 1.25 | 1.29 | |
Operating CF per Share |
0.19 | 0.17 | 0.08 | 0.11 | |
Capex per Share |
(0.07) | (0.06) | (0.07) | (0.06) | |
Free Cash Flow per Share |
0.12 | 0.10 | 0.02 | 0.05 | |
Cash per Share |
0.42 | 0.40 | 0.41 | 0.41 | |
Shareholders Equity per Share |
3.48 | 2.98 | 3.18 | 3.30 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.48 | 2.98 | 3.18 | 3.30 | |
Free Cash Flow |
31.76 | 25.95 | 3.94 | 13.10 | |
Working Capital |
141.01 | 154.31 | 165.17 | 160.68 | |
Capital Expenditures |
(16.65) | (16.38) | (17.05) | (16.16) | |
Net Current Asset Value |
(1,557.03) | (1,640.34) | (1,528.95) | (1,479.10) | |
EV/EBIT |
193.49 | 105.55 | 143.97 | 247.44 | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.05 | |
Net Profit Margin |
(17.81%) | (18.09%) | 21.53% | 3.68% | |
Price to Operating Income |
143.12 | 75.45 | 98.55 | 191.98 | |
| Other line items | |||||
Average Receivables |
68.38 | 71.19 | 68.41 | 72.44 | |
Average Payables |
71.88 | 76.93 | 75.27 | 63.17 | |
Average Inventory |
228.15 | 220.98 | 233.26 | 235.63 | |
Average Assets |
2,978.94 | 2,897.51 | 2,879.50 | 2,865.58 | |
Average Common Equity |
922.58 | 808.78 | 817.57 | 869.38 |
Columns are period end dates